De Lisle Partners’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
Other funds holding NEPH
De Lisle Partners's NEPH Position: Q3 2026 in Review
De Lisle Partners sold out of Nephros (NEPH) in Q3 2026, closing a stake of 17,400 shares — an estimated $62.1K sold.
De Lisle Partners first reported a position in NEPH in Q4 2025 and held it in 3 quarters. The position peaked at $122K in Q4 2025. 36 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.
- De Lisle Partners reported no remaining Nephros position as of Q3 2026 after selling out during the quarter.
- De Lisle Partners sold 17,400 Nephros shares in Q3 2026, an estimated $62.1K.
- De Lisle Partners first reported a position in Nephros in Q4 2025 and held it in 3 quarters.
- De Lisle Partners's Nephros position peaked at $122K in Q4 2025.
- 36 funds tracked by Wall St. Rank held Nephros as of Q3 2026.
Based on De Lisle Partners's 13F filing for Q3 2026, filed 13 Nov 2026.